The latest from the IMI and what it means in practice

The International Myopia Institute released their Volume 1 of reports in 2019 and Volume 2 in 2021. Here, we explore the latest round of reports in 2021 and what they each mean for clinical practice.

IMI 2021 Yearly Digest

The IMI 2021 Yearly Digest summarized recent updates and progress in research of myopia, taking in all publications since the IMI Volume One reports published in early 2019. Each of the Volume One reports included an update – definitions, interventions, genetics, experimental models, clinical trial guidance, ethical considerations and clinical management. While further research is needed, the strengthening evidence base indicates eye care practitioners should embrace proactive myopia management.

IMI Report on Prevention of myopia and its progression

In myopic children, interventions to slow progression are warranted to prevent the development of high myopia and subsequent pathology and also to reduce the economic burden caused by uncorrected and pathologic myopia. This IMI Report describes the latest advice on preventing the development and progression of myopia – read the summary here.

IMI Report on Pathologic Myopia

This IMI Report takes a deep dive into pathological myopia, including its prevalence and defining characteristics. The role of optical coherence tomography (OCT) is discussed, as well as emerging treatment options. Read the summary here.

IMI Report on Accommodation and Binocular Vision in Myopia Development and Progression

This paper has found there are numerous correlations but only weak evidence to demonstrate a causal link between accommodation and myopia development. Assessment of the young myope’s accommodation and binocular vision function is still important. More understanding of the underlying mechanisms for myopia is needed in order to develop evidence-based interventions.

IMI Report on Impact of Myopia

This IMI Report discusses the prevalence of myopia and its impact on both the individual and society. It highlights gaps in our understanding of myopia and provides evidence to support and advocate for developing appropriate approaches and policies to manage myopia. Read the summary here.

IMI – Clinical Management Guidelines Supplementary Digital Content

The landmark International Myopia Institute (IMI) White paper reports were published on 28 February 2019. As lead author on the Clinical Management Guidelines paper, I was thrilled to see the work of my 13 co-authors and I shared with a keen clinician audience worldwide.